169 related articles for article (PubMed ID: 17456039)
1. Structural elements of ligand recognition site in secretory phospho-lipase A2 and structure-based design of specific inhibitors.
Singh N; Somvanshi RK; Sharma S; Dey S; Kaur P; Singh TP
Curr Top Med Chem; 2007; 7(8):757-64. PubMed ID: 17456039
[TBL] [Abstract][Full Text] [Related]
2. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
[TBL] [Abstract][Full Text] [Related]
3. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
[TBL] [Abstract][Full Text] [Related]
4. Structures and binding studies of the complexes of phospholipase A2 with five inhibitors.
Shukla PK; Gautam L; Sinha M; Kaur P; Sharma S; Singh TP
Biochim Biophys Acta; 2015 Apr; 1854(4):269-77. PubMed ID: 25541253
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human secretory class II phospholipase A2 by heparin.
Dua R; Cho W
Eur J Biochem; 1994 Apr; 221(1):481-90. PubMed ID: 8168536
[TBL] [Abstract][Full Text] [Related]
6. [Diversity of phospholipases A2 and their functions].
Bereziat G
C R Seances Soc Biol Fil; 1996; 190(4):409-16. PubMed ID: 8952891
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationship (QSAR) analysis of a series of indole analogues as inhibitor for human group V secretory phospholipase A2.
OmPraba G; Velmurugan D
Indian J Biochem Biophys; 2006 Jun; 43(3):154-9. PubMed ID: 16967904
[TBL] [Abstract][Full Text] [Related]
8. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution.
Chandra V; Jasti J; Kaur P; Betzel Ch; Srinivasan A; Singh TP
J Mol Biol; 2002 Jul; 320(2):215-22. PubMed ID: 12079380
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and structural properties of disulfide engineered phospholipase A2: insight into the role of disulfide bonding patterns.
Yu BZ; Pan YH; Janssen MJ; Bahnson BJ; Jain MK
Biochemistry; 2005 Mar; 44(9):3369-79. PubMed ID: 15736947
[TBL] [Abstract][Full Text] [Related]
10. Membrane Association Allosterically Regulates Phospholipase A
Mouchlis VD; Dennis EA
Acc Chem Res; 2022 Dec; 55(23):3303-3311. PubMed ID: 36315840
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a class XIB phospholipase A2 (PLA2): rice (oryza sativa) isoform-2 pla2 and an octanoate complex.
Guy JE; Ståhl U; Lindqvist Y
J Biol Chem; 2009 Jul; 284(29):19371-9. PubMed ID: 19457861
[TBL] [Abstract][Full Text] [Related]
12. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid and phospholipid selectivity of different phospholipase A2 enzymes studied by using a mammalian membrane as substrate.
Diez E; Chilton FH; Stroup G; Mayer RJ; Winkler JD; Fonteh AN
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):721-6. PubMed ID: 8053897
[TBL] [Abstract][Full Text] [Related]
14. A molecular dynamics study of the three-dimensional model of human synovial fluid phospholipase A2--transition state mimic complexes.
Hariprasad V; Kulkarni VM
J Mol Recognit; 1996; 9(2):95-102. PubMed ID: 8877799
[TBL] [Abstract][Full Text] [Related]
15. Interactions of N-terminal fragments of groups I and II phospholipases A2 with phospholipid bilayers and their surface recognition properties.
Kato T; Lee S; Oishi O; Aoyagi H; Ohno M
Biochim Biophys Acta; 1994 Mar; 1211(2):215-20. PubMed ID: 8117749
[TBL] [Abstract][Full Text] [Related]
16. Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence.
Tseng A; Inglis AS; Scott KF
J Biol Chem; 1996 Sep; 271(39):23992-8. PubMed ID: 8798633
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of phospholipase A2 complex with the hydrolysis products of platelet activating factor: equilibrium binding of fatty acid and lysophospholipid-ether at the active site may be mutually exclusive.
Pan YH; Yu BZ; Berg OG; Jain MK; Bahnson BJ
Biochemistry; 2002 Dec; 41(50):14790-800. PubMed ID: 12475227
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: Insights into Ca2+-independent catalytic mechanism.
Corrêa LC; Marchi-Salvador DP; Cintra AC; Sampaio SV; Soares AM; Fontes MR
Biochim Biophys Acta; 2008 Apr; 1784(4):591-9. PubMed ID: 18261474
[TBL] [Abstract][Full Text] [Related]
19. Binding of porcine pancreatic phospholipase A2 to various micellar substrate analogues. Involvement of histidine-48 and aspartic acid-49 in the binding process.
Donné-Op den Kelder GM; Hille JD; Dijkman R; de Haas GH; Egmond MR
Biochemistry; 1981 Jul; 20(14):4074-8. PubMed ID: 7284311
[TBL] [Abstract][Full Text] [Related]
20. Structure of recombinant human rheumatoid arthritic synovial fluid phospholipase A2 at 2.2 A resolution.
Wery JP; Schevitz RW; Clawson DK; Bobbitt JL; Dow ER; Gamboa G; Goodson T; Hermann RB; Kramer RM; McClure DB
Nature; 1991 Jul; 352(6330):79-82. PubMed ID: 2062381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
